0000814133-18-000004.txt : 20180205
0000814133-18-000004.hdr.sgml : 20180205
20180205130220
ACCESSION NUMBER: 0000814133-18-000004
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20180205
DATE AS OF CHANGE: 20180205
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-59049
FILM NUMBER: 18573541
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC
DATE OF NAME CHANGE: 20000208
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: WASATCH ADVISORS INC
CENTRAL INDEX KEY: 0000814133
IRS NUMBER: 870319391
STATE OF INCORPORATION: UT
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 505 WAKARA WAY
STREET 2: 3RD FLOOR
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 8015330777
MAIL ADDRESS:
STREET 1: 505 WAKARA WAY
STREET 2: 3RD FLOOR
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
SC 13G/A
1
sgmo218.txt
SCHEDULE 13G
Amendment No. 4
Name of Issuer: Sangamo Biosciences Inc.
Title of Class of Securities: Common Stock
CUSIP Number: 800677106
Item 1: Reporting Person: Wasatch Advisors, Inc. 87-0319391
Item 2: Check Box If Member of Group: Not Applicable
Item 3: SEC Use
Item 4: Place of Organization: Utah
Items 5-8: Number of Shares Owned With:
Item 5: Sole Voting Power: 3,864,628
Item 6: Shared Voting Power: 0
Item 7: Sole Dispositive Power: 3,864,628
Item 8: Shared Dispositive Power: 0
Item 9: Aggregate Amount Owned: 3,864,628
Item 10: Check Box If Aggregate Amount Excludes Certain Shares: N/A
Item 11: Percent of Class Owned: 4.6%
Item 12: Type of Reporting Person: IA
Item 1(a): Name of Issuer: Sangamo Biosciences Inc.
Item l(b): Address of Issuer:
501 Canal Blvd, Point Richmond Tech Cntr II, Richmond, CA 94804
Item 2(a): Name of Person Filing: Wasatch Advisors, Inc.
Item 2(b): Address: 505 Wakara Way, Salt Lake City, UT 84108
Item 2(c): Citizenship: Not Applicable
Item 2(d): Title of Class of Securities: Common Stock
Item 2(e): CUSIP Number: 800677106
Item 3(e): Investment Adviser registered under section 203 of the Investment
Advisers Act of 1940
Item 4(a): Amount Owned: 3,864,628
Item 4(b): Percent of Class Owned: 4.6%
Item 4(c)(i): Sole Voting Power: 3,864,628
Item 4(c)(ii): Shared Voting Power: 0
Item 4(c)(iii): Sole Dispositive Power: 3,864,628
Item 4(c)(iv): Shared Dispositive Power: 0
Item 5: Check Box If Ownership Is 5% or Less of Class: [X]
Item 6. Ownership of More Than 5% on Behalf of Another Person: N/A
Item 7: Identification of Subsidiary: Not Applicable
Item 8: Identification of Members of Group: Not Applicable
Item 9: Notice of Dissolution of Group: Not Applicable
Item 10: Certification:
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect
of changing or influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in any transaction
having such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct as of January 31, 2018.
Date: 02/05/18
Signature: /s/JB Taylor
Name/Title: JB Taylor/CEO